|
V.V. Kaliuzhin, O.F. Sibirtseva, O.I. Urazova, E.V. Kaliuzhina, L.M. Tkalich, Li.I. Zibnitskaya, R.N. Kolesnikov, V.Yu. Grankina
Laboratory markers of haemosthasis panel in prognosing of progression of chronic kidney disease
|
№3 / 2012
|
|
A.P. Rebrov, O.G. Kargalskaya
Prevalence of chronic kidney disease in patients with psoriatic arthritis
|
№3 / 2012
|
|
Yu.A. Pigareva, S.V. Avdoshina, T.B. Dmitrova, M.A. Efremovtseva, Zh.G. Tigay
Prevalence of chronic kidney disease in patients of clinic of internal diseases
|
№3 / 2012
|
|
E.M. Shilov, E.I. Levankovskaya, M.S. Novikova
New approaches in treatment of chronic kidney disease in metabolic syndrome
|
№2 / 2012
|
|
T.E. Rudenko, I.M. Kutyrina, M.Yu. Shvetsov
Lipid metabolism in chronic kidney disease
|
№2 / 2012
|
|
N.A. Moukhin
Difficult nephrological patient today
|
№2 / 2012
|
|
M.S. Molchanova, E.E. Tikhomirov, L.P. Bykova, E.A. Molchanova, A.L. Rumiantsev, A.L. Valov, D.B. Ektov, V.A. Gavrilova, Yu.B. Yurasova, E.K. Petrosian
Role of R990G polymorphism of calcium-sensing receptor gene in regulation of parathyroid hormone level in children with chronic kidney disease stage II–V
|
№1 / 2012
|
|
Kulina E.V.
Role of omega-3 unsaturated fatty acids in treatment of progressive kidney diseases
|
№6 / 2011
|
|
V.V. Fomin. L.V. Kozlovskaya, Yu.S. Milovanov
Cardiomyopathy in anemia, associated with chronic kidney disease: role of erythropoetin-beta
|
№6 / 2011
|
|
A.P. Rebrov, E.V. Voloshinova, M.A. Tiapkina
Prevalence of chronic kidney disease and it’s etiological structure in patients with rheumatoid arthritis
|
№6 / 2011
|
|
Jh.D. Koblava, M.A. Efremovtseva, S.V. Villevalde
Cardio-renal syndromes
|
№6 / 2011
|
|
L.V. Kozlovskaya, Yu.S. Milovanova, L.Yu. Milovanova
Optimal target hemoglobin level in chronic kidney disease patients, treated with erythropoesis-stimulating agents: controversial questions
|
№5 / 2011
|
Русский
